PMV Pharmaceuticals
PMVP
PMVP
104 hedge funds and large institutions have $333M invested in PMV Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 41 increasing their positions, 33 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
1.14% less ownership
Funds ownership: 113.06% → 111.92% (-1.1%)
2% less funds holding
Funds holding: 106 → 104 (-2)
20% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 10
Holders
104
Holding in Top 10
3
Calls
$3.98M
Puts
$1.6M
Top Buyers
| 1 | +$6.55M | |
| 2 | +$5.33M | |
| 3 | +$4.07M | |
| 4 |
OCA
Octagon Capital Advisors
New York
|
+$2.66M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$2.61M |
Top Sellers
| 1 | -$4.44M | |
| 2 | -$4.01M | |
| 3 | -$1.26M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.18M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$996K |